arrow_back Back to App

Strengthening Biomedical Research: Investing in Health and Innovation

This resolution emphasizes the Federal Government's duty to lead in biomedical research, which is crucial for improving citizens' health. It highlights the need for increased investment in science to develop new drugs and therapies, directly impacting Americans' quality of life and longevity.
Key points
Increased investment in medical research can lead to new drugs and therapies for diseases like cancer, heart disease, diabetes, and Alzheimer's, improving health and life expectancy.
Support for scientists and stable research funding aims to ensure the United States remains a leader in medical innovation, translating into access to modern treatments for citizens.
The importance of scientific research independence from political interference is stressed to ensure the credibility and effectiveness of medical discoveries, building trust in the healthcare system.
article Official text account_balance Process page
Introduced
Citizen Poll
No votes cast
Additional Information
Print number: 119_HRES_601
Sponsor: Rep. DeGette, Diana [D-CO-1]
Process start date: 2025-07-23
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Recognizing the duty of the Federal Government to lead the world in biomedical research.

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_HRES_601.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2025-07-23.

What are the main provisions?

Key points include:

  • Increased investment in medical research can lead to new drugs and therapies for diseases like cancer, heart disease, diabetes, and Alzheimer's, improving health and life expectancy.
  • Support for scientists and stable research funding aims to ensure the United States remains a leader in medical innovation, translating into access to modern treatments for citizens.
  • The importance of scientific research independence from political interference is stressed to ensure the credibility and effectiveness of medical discoveries, building trust in the healthcare system.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. DeGette, Diana [D-CO-1].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Energy and Commerce.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-21.

CATEGORIES

Health Public Investments Economy